Latest Updates on JAZZ
-
Cannabis The Medical Marijuana Stock to Buy Before the Schedule I Change
The FDA's Schedule I label on cannabis is the single biggest barrier holding medical marijuana stocks back.That barrier could be coming down soon, and you'll want to own shares of GW Pharmaceuticals when it does.Lo and behold - a bill … Read more » -
Cannabis There's Still Some Time to Move on This Must-Own Biotech
Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.And there's one innovative company that puts you right in the middle of the sector's market-crushing … Read more » -
stocks The 3 Best Biotech Stocks to Buy in June 2018
By 2025, the biotech industry will be worth will be $727 billion - a 120% increase over its total value in 2015. To help you take advantage of the tremendous gains in biotech stocks, we're bringing you the three best biotech stocks to buy … Read more » -
Stocks The 3 Best Biotech Stocks to Buy Today
Since hitting a high in late January, the iShares Nasdaq Biotechnology ETF has slumped more than 11%. But that doesn't mean investors should stop looking for the best biotech stocks to buy today. You see, the slump in biotech stocks has … Read more » -
Biotechnology Biotech Stocks Are Ready to Break Out, So Grab These 3 Deals Now
Biotech stocks have been getting hit hard in early 2018, but it's largely because of market overreactions to minor setbacks and rumors. Based on earnings and assets, some biotech stocks are now available at remarkable discounts. Read more » -
Stocks The Best Stocks to Buy Now: Take a Ride on the Road to Wealth
Our latest round of stocks to buy now is heavy on tech. These stocks capitalize on legal marijuana, tailwinds in the biotech industry, a race to build a supercomputer, and the urbanization of the tech industry. Read more » -
Biotechnology Three Biotech Bargains to Buy Right Now
Back in October, I did something crazy. That's when I told the paid-up members of my Radical Technology Profits trading service to buy a small-cap biotech stock. Here's why that move was a bit … Read more » -
Biotech Investing $30 Billion Deal Between Top Pharmaceutical Companies Is a Major Buy Signal
Another possible deal between two of the world's top pharmaceutical companies was announced this week when Shire Plc. (Nasdaq: SHPG) made an unsolicited offer of $30.6 billion for Baxalta Inc. (NYSE: BXLT). Money Morning Defense & … Read more »
